Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 70%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 60% · prior close shown (market closed)
Limited proprietary earnings coverage for REPL yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 0d ago
Reported figures for Replimune Group, Inc. — research only, not investment advice.
Updated
What happened recently for Replimune Group, Inc. (REPL) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$14.97
Market cap
$1.41B
Profitable
No
Net income
$-313.94M
FY Mar 31, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Replimune Group, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Replimune Group, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.